Filing Details

Accession Number:
0001209191-19-042970
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-23 16:32:08
Reporting Period:
2019-07-22
Accepted Time:
2019-07-23 16:32:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759425 Mirum Pharmaceuticals Inc. MIRM () G7
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1388325 A/S Holdings Novo Tuborg Havnevej 19
Hellerup G7 2900
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-22 1,870,147 $0.00 1,870,147 No 4 C Direct
Common Stock Acquisiton 2019-07-22 575,000 $15.00 2,445,147 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock SERIES A PREFERRED STOCK Disposition 2019-07-22 1,870,147 $0.00 1,870,147 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
Footnotes
  1. Each share of Series A Preferred Stock converted automatically into one share of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date.
  2. Represents a purchase from the underwriters in the Issuer's initial public offering.